The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biopharmaceutical CMO Services Market Research Report 2025
Synopsis
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global Biopharmaceutical CMO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical CMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical CMO Services.
Report Scope
The Biopharmaceutical CMO Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical CMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical CMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant
Segment by Type
Biologics Manufacturing
Biosimilars Manufacturing
Others
Segment by Application
Clinical Manufacturing
Commercial Manufacturing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical CMO Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global Biopharmaceutical CMO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical CMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical CMO Services.
Report Scope
The Biopharmaceutical CMO Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical CMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical CMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant
Segment by Type
Biologics Manufacturing
Biosimilars Manufacturing
Others
Segment by Application
Clinical Manufacturing
Commercial Manufacturing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical CMO Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biologics Manufacturing
1.2.3 Biosimilars Manufacturing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Manufacturing
1.3.3 Commercial Manufacturing
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO Services Market Perspective (2019-2030)
2.2 Biopharmaceutical CMO Services Growth Trends by Region
2.2.1 Global Biopharmaceutical CMO Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biopharmaceutical CMO Services Historic Market Size by Region (2019-2024)
2.2.3 Biopharmaceutical CMO Services Forecasted Market Size by Region (2025-2030)
2.3 Biopharmaceutical CMO Services Market Dynamics
2.3.1 Biopharmaceutical CMO Services Industry Trends
2.3.2 Biopharmaceutical CMO Services Market Drivers
2.3.3 Biopharmaceutical CMO Services Market Challenges
2.3.4 Biopharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO Services Players by Revenue (2019-2024)
3.1.2 Global Biopharmaceutical CMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical CMO Services Revenue
3.4 Global Biopharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO Services Revenue in 2023
3.5 Biopharmaceutical CMO Services Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical CMO Services Product Solution and Service
3.7 Date of Enter into Biopharmaceutical CMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO Services Breakdown Data by Type
4.1 Global Biopharmaceutical CMO Services Historic Market Size by Type (2019-2024)
4.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2025-2030)
5 Biopharmaceutical CMO Services Breakdown Data by Application
5.1 Global Biopharmaceutical CMO Services Historic Market Size by Application (2019-2024)
5.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biopharmaceutical CMO Services Market Size (2019-2030)
6.2 North America Biopharmaceutical CMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biopharmaceutical CMO Services Market Size by Country (2019-2024)
6.4 North America Biopharmaceutical CMO Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO Services Market Size (2019-2030)
7.2 Europe Biopharmaceutical CMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biopharmaceutical CMO Services Market Size by Country (2019-2024)
7.4 Europe Biopharmaceutical CMO Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO Services Market Size (2019-2030)
8.2 Asia-Pacific Biopharmaceutical CMO Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO Services Market Size (2019-2030)
9.2 Latin America Biopharmaceutical CMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biopharmaceutical CMO Services Market Size by Country (2019-2024)
9.4 Latin America Biopharmaceutical CMO Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO Services Market Size (2019-2030)
10.2 Middle East & Africa Biopharmaceutical CMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Biopharmaceutical CMO Services Introduction
11.1.4 Catalent Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Biopharmaceutical CMO Services Introduction
11.2.4 Thermo Fisher Scientific Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Biopharmaceutical CMO Services Introduction
11.3.4 Lonza Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Biopharmaceutical CMO Services Introduction
11.4.4 Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Biopharmaceutical CMO Services Introduction
11.5.4 Fareva Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Detail
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Biopharmaceutical CMO Services Introduction
11.6.4 Recipharm Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Detail
11.7.2 Aenova Business Overview
11.7.3 Aenova Biopharmaceutical CMO Services Introduction
11.7.4 Aenova Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Biopharmaceutical CMO Services Introduction
11.8.4 AbbVie Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Detail
11.9.2 Baxter Business Overview
11.9.3 Baxter Biopharmaceutical CMO Services Introduction
11.9.4 Baxter Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Detail
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Biopharmaceutical CMO Services Introduction
11.10.4 Nipro Corp Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Detail
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Biopharmaceutical CMO Services Introduction
11.11.4 Sopharma Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Detail
11.12.2 Famar Business Overview
11.12.3 Famar Biopharmaceutical CMO Services Introduction
11.12.4 Famar Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Detail
11.13.2 Vetter Business Overview
11.13.3 Vetter Biopharmaceutical CMO Services Introduction
11.13.4 Vetter Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Detail
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Biopharmaceutical CMO Services Introduction
11.14.4 Shandong Xinhua Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Detail
11.15.2 Piramal Business Overview
11.15.3 Piramal Biopharmaceutical CMO Services Introduction
11.15.4 Piramal Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Detail
11.16.2 Mylan Business Overview
11.16.3 Mylan Biopharmaceutical CMO Services Introduction
11.16.4 Mylan Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Detail
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Biopharmaceutical CMO Services Introduction
11.17.4 Dr. Reddy’s Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Detail
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Biopharmaceutical CMO Services Introduction
11.18.4 Zhejiang Hisun Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Detail
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Biopharmaceutical CMO Services Introduction
11.19.4 Zhejiang Huahai Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Detail
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Biopharmaceutical CMO Services Introduction
11.20.4 Jubilant Revenue in Biopharmaceutical CMO Services Business (2019-2024)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biopharmaceutical CMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Biologics Manufacturing
Table 3. Key Players of Biosimilars Manufacturing
Table 4. Key Players of Others
Table 5. Global Biopharmaceutical CMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Biopharmaceutical CMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Biopharmaceutical CMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Biopharmaceutical CMO Services Market Share by Region (2019-2024)
Table 9. Global Biopharmaceutical CMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Biopharmaceutical CMO Services Market Share by Region (2025-2030)
Table 11. Biopharmaceutical CMO Services Market Trends
Table 12. Biopharmaceutical CMO Services Market Drivers
Table 13. Biopharmaceutical CMO Services Market Challenges
Table 14. Biopharmaceutical CMO Services Market Restraints
Table 15. Global Biopharmaceutical CMO Services Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Biopharmaceutical CMO Services Market Share by Players (2019-2024)
Table 17. Global Top Biopharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2023)
Table 18. Ranking of Global Top Biopharmaceutical CMO Services Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Biopharmaceutical CMO Services Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biopharmaceutical CMO Services Product Solution and Service
Table 22. Date of Enter into Biopharmaceutical CMO Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biopharmaceutical CMO Services Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2019-2024)
Table 26. Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2025-2030)
Table 28. Global Biopharmaceutical CMO Services Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2019-2024)
Table 30. Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2025-2030)
Table 32. North America Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Biopharmaceutical CMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Biopharmaceutical CMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Biopharmaceutical CMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Biopharmaceutical CMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Biopharmaceutical CMO Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Biopharmaceutical CMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Biopharmaceutical CMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 47. Catalent Company Detail
Table 48. Catalent Business Overview
Table 49. Catalent Biopharmaceutical CMO Services Product
Table 50. Catalent Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 51. Catalent Recent Development
Table 52. Thermo Fisher Scientific Company Detail
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Biopharmaceutical CMO Services Product
Table 55. Thermo Fisher Scientific Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Lonza Company Detail
Table 58. Lonza Business Overview
Table 59. Lonza Biopharmaceutical CMO Services Product
Table 60. Lonza Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 61. Lonza Recent Development
Table 62. Boehringer Ingelheim Company Detail
Table 63. Boehringer Ingelheim Business Overview
Table 64. Boehringer Ingelheim Biopharmaceutical CMO Services Product
Table 65. Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 66. Boehringer Ingelheim Recent Development
Table 67. Fareva Company Detail
Table 68. Fareva Business Overview
Table 69. Fareva Biopharmaceutical CMO Services Product
Table 70. Fareva Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 71. Fareva Recent Development
Table 72. Recipharm Company Detail
Table 73. Recipharm Business Overview
Table 74. Recipharm Biopharmaceutical CMO Services Product
Table 75. Recipharm Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 76. Recipharm Recent Development
Table 77. Aenova Company Detail
Table 78. Aenova Business Overview
Table 79. Aenova Biopharmaceutical CMO Services Product
Table 80. Aenova Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 81. Aenova Recent Development
Table 82. AbbVie Company Detail
Table 83. AbbVie Business Overview
Table 84. AbbVie Biopharmaceutical CMO Services Product
Table 85. AbbVie Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 86. AbbVie Recent Development
Table 87. Baxter Company Detail
Table 88. Baxter Business Overview
Table 89. Baxter Biopharmaceutical CMO Services Product
Table 90. Baxter Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 91. Baxter Recent Development
Table 92. Nipro Corp Company Detail
Table 93. Nipro Corp Business Overview
Table 94. Nipro Corp Biopharmaceutical CMO Services Product
Table 95. Nipro Corp Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 96. Nipro Corp Recent Development
Table 97. Sopharma Company Detail
Table 98. Sopharma Business Overview
Table 99. Sopharma Biopharmaceutical CMO Services Product
Table 100. Sopharma Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 101. Sopharma Recent Development
Table 102. Famar Company Detail
Table 103. Famar Business Overview
Table 104. Famar Biopharmaceutical CMO Services Product
Table 105. Famar Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 106. Famar Recent Development
Table 107. Vetter Company Detail
Table 108. Vetter Business Overview
Table 109. Vetter Biopharmaceutical CMO Services Product
Table 110. Vetter Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 111. Vetter Recent Development
Table 112. Shandong Xinhua Company Detail
Table 113. Shandong Xinhua Business Overview
Table 114. Shandong Xinhua Biopharmaceutical CMO Services Product
Table 115. Shandong Xinhua Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 116. Shandong Xinhua Recent Development
Table 117. Piramal Company Detail
Table 118. Piramal Business Overview
Table 119. Piramal Biopharmaceutical CMO Services Product
Table 120. Piramal Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 121. Piramal Recent Development
Table 122. Mylan Company Detail
Table 123. Mylan Business Overview
Table 124. Mylan Biopharmaceutical CMO Services Product
Table 125. Mylan Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 126. Mylan Recent Development
Table 127. Dr. Reddy’s Company Detail
Table 128. Dr. Reddy’s Business Overview
Table 129. Dr. Reddy’s Biopharmaceutical CMO Services Product
Table 130. Dr. Reddy’s Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 131. Dr. Reddy’s Recent Development
Table 132. Zhejiang Hisun Company Detail
Table 133. Zhejiang Hisun Business Overview
Table 134. Zhejiang Hisun Biopharmaceutical CMO Services Product
Table 135. Zhejiang Hisun Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 136. Zhejiang Hisun Recent Development
Table 137. Zhejiang Huahai Company Detail
Table 138. Zhejiang Huahai Business Overview
Table 139. Zhejiang Huahai Biopharmaceutical CMO Services Product
Table 140. Zhejiang Huahai Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 141. Zhejiang Huahai Recent Development
Table 142. Jubilant Company Detail
Table 143. Jubilant Business Overview
Table 144. Jubilant Biopharmaceutical CMO Services Product
Table 145. Jubilant Revenue in Biopharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 146. Jubilant Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical CMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biopharmaceutical CMO Services Market Share by Type: 2023 VS 2030
Figure 3. Biologics Manufacturing Features
Figure 4. Biosimilars Manufacturing Features
Figure 5. Others Features
Figure 6. Global Biopharmaceutical CMO Services Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Biopharmaceutical CMO Services Market Share by Application: 2023 VS 2030
Figure 8. Clinical Manufacturing Case Studies
Figure 9. Commercial Manufacturing Case Studies
Figure 10. Others Case Studies
Figure 11. Biopharmaceutical CMO Services Report Years Considered
Figure 12. Global Biopharmaceutical CMO Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Biopharmaceutical CMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Biopharmaceutical CMO Services Market Share by Region: 2023 VS 2030
Figure 15. Global Biopharmaceutical CMO Services Market Share by Players in 2023
Figure 16. Global Top Biopharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO Services Revenue in 2023
Figure 18. North America Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Biopharmaceutical CMO Services Market Share by Country (2019-2030)
Figure 20. United States Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Biopharmaceutical CMO Services Market Share by Country (2019-2030)
Figure 24. Germany Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Biopharmaceutical CMO Services Market Share by Region (2019-2030)
Figure 32. China Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Biopharmaceutical CMO Services Market Share by Country (2019-2030)
Figure 40. Mexico Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Biopharmaceutical CMO Services Market Share by Country (2019-2030)
Figure 44. Turkey Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Biopharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Catalent Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 48. Lonza Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 50. Fareva Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 51. Recipharm Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 52. Aenova Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 53. AbbVie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 54. Baxter Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 55. Nipro Corp Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 56. Sopharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 57. Famar Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 58. Vetter Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 59. Shandong Xinhua Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 60. Piramal Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 61. Mylan Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 62. Dr. Reddy’s Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 63. Zhejiang Hisun Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 64. Zhejiang Huahai Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 65. Jubilant Revenue Growth Rate in Biopharmaceutical CMO Services Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
